CAS number: 59-92-7
Plant Source: Mucuna Pruriens
Appearance: White powder
Molecular formula: C9H11NO4
Molecular weight: 197.188
Test method: HPLC
Specification:BP2009, 99%
Levodopa is a prodrug of dopamine that is administered to patients with Parkinson’s due to its ability to cross the blood-brain barrierLabel. Levodopa can be metabolised to dopamine on either side of the blood-brain barrier and so it is generally administered with a dopa decarboxylase inhibitor like carbidopa to prevent metabolism until after it has crossed the blood-brain barrierLabel,1. Once past the blood-brain barrier, levodopa is metabolized to dopamine and supplements the low endogenous levels of dopamine to treat symptoms of Parkinson’sLabel. The first developed drug product that was approved by the FDA was a levodopa and carbidopa combined product called Sinemet that was approved on May 2, 1975.
Product packing: 25kg/drum
Validity period: 2 years
